Pharmaceutical companies are strategizing how to muzzle Medicare’s future power to negotiate drug prices, The Wall Street Journal reported Oct. 20.
Read the full post on Becker's Hospital Review - Healthcare News
Drugmakers look to curb Inflation Reduction Act
